Patent · US Active

Inhibitors of cyclin-dependent kinases

US11447493B2 · kind B2 · utility

0Cited by
2References
19Claims
0Family size

Inventors

Key dates

Filing dateMay 2, 2019
Grant dateSep 20, 2022
Priority date—
Expiry dateMay 20, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are inhibitors of cyclin-dependent kinases (CDKs), pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.